Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 07-2022 | 06-2022 | 04-2022 | 03-2022 | 01-2022 | |
| Operating Expenses | 523 | 371 | 371 | 445 | 445 |
| Operating Income | -523 | -371 | -371 | -445 | -445 |
| Other Income | 596 | 113 | 113 | 42 | 42 |
| Pre-tax Income | 73 | -258 | -258 | -404 | -404 |
| Net Income Continuous | -258 | -258 | -404 | -404 | -404 |
| Net Income | $73 | $-258 | $-258 | $-404 | $-404 |
| EPS Basic Total Ops | N/A | -0.02 | N/A | -0.03 | N/A |
| EPS Basic Continuous Ops | N/A | -0.08 | N/A | -0.13 | N/A |
| EPS Diluted Total Ops | N/A | -0.02 | N/A | -0.03 | N/A |
| EPS Diluted Continuous Ops | N/A | -0.08 | N/A | -0.13 | N/A |
| EBITDA(a) | $-523 | $-371 | $-371 | $-445 | $-445 |